IQuum | GenomeWeb

IQuum

NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.

CHICAGO (GenomeWeb) — Roche Diagnostics this week provided a window into its business strategy, particularly in the area of molecular diagnostics where, over the last several months, the company has made a number of moves designed to position itself as "the most comprehensive provider of solution

NEW YORK (GenomeWeb) — BioMérieux said this week that its first quarter revenues increased 3 percent year over year but 8 percent when including sales from recent acquisition BioFire Diagnostics and at constant exchange rates.

Roche's acquisition of privately held Boston-area molecular diagnostics developer Iquum, announced earlier this week, is expected to fill a hole in Roche's product portfolio, gi

NEW YORK (GenomeWeb News) — Roche said today that it has acquired Iquum, a privately held company developing point-of-care molecular diagnostics.

ABgene (Thermo Fisher) of Surrey, UK, has been awarded US Patent No. D679,830, "PCR multiwell plate."
Simon May, Jeffrey Coulling, Clive Harrison, and Nicola Burbidge are named as inventors.

NEW YORK (GenomeWeb News) – The Department of Defense has awarded more than $23 million to three firms for the development of a platform and assays to detect biological warfare agents, the agency announced last week.

The University of North Carolina at Chapel Hill has been awarded US Patent No. 8,148,511, "Methods and compositions for the detection and quantification of E. coli and Enterococcus."

By Ben Butkus
Clinical diagnostic test maker Iquum this week received US Food and Drug Administration clearance for its Liat Influenza A/B assay and fully automated and integrated Liat Analyzer.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Food and Drug Administration has given 510(k) clearance to IQuum's assay for detecting and differentiating influenza A and B in about 20 minutes, the company announced today.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.